More: 34th Annual North American Neuro-Ophthalmology Society (NANOS) Meeting

Highlights of the 34th Annual North American Neuro-Ophthalmology Society (NANOS) Meeting CME

March 8 - 13, 2008, Orlando, FL

Author Information and Disclosures

This activity is not sanctioned by, nor a part of, the 34th Annual North American Neuro-Ophthalmology Society Meeting.

Release Date: April 15, 2008; Valid for credit through April 15, 2009

Credits Available
Physicians - maximum of 0.25 AMA PRA Category 1 Credit(s)™ for physicians

To participate in this internet activity: (1) review the target audience, learning objectives, and author disclosures; (2) study the education content; (3) take the post-test and/or complete the evaluation; (4) view/print certificate View details.

Legal Disclaimer

The material presented here does not necessarily reflect the views of Medscape or companies that support educational programming on www.medscape.com. These materials may discuss therapeutic products that have not been approved by the US Food and Drug Administration and off-label uses of approved products. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity.

The materials presented here were prepared by independent authors under the editorial supervision of Medscape and do not represent a publication of the 34th Annual North American Neuro-Ophthalmology Society Meeting. These materials and the related activity are not sanctioned by the 34th Annual North American Neuro-Ophthalmology Society Meeting or the commercial supporter of the conference, and do not constitute an official part of that conference.

Copyright © 2008 Medscape.
Medscape
Learning Objectives

Upon completion of this activity, participants will be able to:

  1. Review evidence-based recommendations for acute stroke treatment and secondary stroke prevention and how they relate to the eye
  2. Discuss the visual symptoms that accompany early neurodegenerative disease and the ophthalmologic therapies to help patients with neurodegenerative diseases
  3. Evaluate the results of studies focusing on neuro-ophthalmologic conditions, including optic neuropathy and idiopathic intracranial hypertension
Authors and Disclosures

Nancy J. Newman, MD
Disclosure: Nancy J. Newman, MD, has disclosed no relevant financial relationships.


Charlotte Warren
Disclosure: Charlotte Warren has disclosed no relevant financial relationships.
 
Medscape
Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Medscape, LLC designates this educational activity for a maximum of 0.25 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Contact This Provider

All material on this website is protected by copyright, Copyright © 1994-2008 by Medscape. This website also contains material copyrighted by 3rd parties.